Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement - PubMed (original) (raw)
Clinical Trial
Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement
D Heber et al. Am J Clin Nutr. 1999 Feb.
Abstract
Background: We examined the cholesterol-lowering effects of a proprietary Chinese red-yeast-rice supplement in an American population consuming a diet similar to the American Heart Association Step I diet using a double-blind, placebo-controlled, prospectively randomized 12-wk controlled trial at a university research center.
Objective: We evaluated the lipid-lowering effects of this red-yeast-rice dietary supplement in US adults separate from effects of diet alone.
Design: Eighty-three healthy subjects (46 men and 37 women aged 34-78 y) with hyperlipidemia [total cholesterol, 5.28-8.74 mmol/L (204-338 mg/dL); LDL cholesterol, 3.31-7.16 mmol/L (128-277 mg/dL); triacylglycerol, 0.62-2.78 mmol/L (55-246 mg/dL); and HDL cholesterol 0.78-2.46 mmol/L (30-95 mg/dL)] who were not being treated with lipid-lowering drugs participated. Subjects were treated with red yeast rice (2.4 g/d) or placebo and instructed to consume a diet providing 30% of energy from fat, <10% from saturated fat, and <300 mg cholesterol daily. Main outcome measures were total cholesterol, total triacylglycerol, and HDL and LDL cholesterol measured at weeks 8, 9, 11, and 12.
Results: Total cholesterol concentrations decreased significantly between baseline and 8 wk in the red-yeast-rice-treated group compared with the placebo-treated group [(x+/-SD) 6.57+/-0.93 mmol/L (254+/-36 mg/dL) to 5.38+/-0.80 mmol/L (208+/-31 mg/dL); P < 0.001]. LDL cholesterol and total triacylglycerol were also reduced with the supplement. HDL cholesterol did not change significantly.
Conclusions: Red yeast rice significantly reduces total cholesterol, LDL cholesterol, and total triacylglycerol concentrations compared with placebo and provides a new, novel, food-based approach to lowering cholesterol in the general population.
Comment in
- Dietary supplement or drug? The case for cholestin.
Heber D. Heber D. Am J Clin Nutr. 1999 Jul;70(1):106-8. doi: 10.1093/ajcn/70.1.106. Am J Clin Nutr. 1999. PMID: 10393149 No abstract available. - More on the Chinese red-yeast-rice supplement and its cholesterol-lowering effect.
Bliznakov EG. Bliznakov EG. Am J Clin Nutr. 2000 Jan;71(1):152-4. doi: 10.1093/ajcn/71.1.152. Am J Clin Nutr. 2000. PMID: 10617960 No abstract available.
Similar articles
- The effect of a plant-based diet on plasma lipids in hypercholesterolemic adults: a randomized trial.
Gardner CD, Coulston A, Chatterjee L, Rigby A, Spiller G, Farquhar JW. Gardner CD, et al. Ann Intern Med. 2005 May 3;142(9):725-33. doi: 10.7326/0003-4819-142-9-200505030-00007. Ann Intern Med. 2005. PMID: 15867404 Clinical Trial. - Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.
Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. Becker DJ, et al. Ann Intern Med. 2009 Jun 16;150(12):830-9, W147-9. doi: 10.7326/0003-4819-150-12-200906160-00006. Ann Intern Med. 2009. PMID: 19528562 Clinical Trial. - A softgel dietary supplement containing esterified plant sterols and stanols improves the blood lipid profile of adults with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled replication study.
McKenney JM, Jenks BH, Shneyvas E, Brooks JR, Shenoy SF, Cook CM, Maki KC. McKenney JM, et al. J Acad Nutr Diet. 2014 Feb;114(2):244-249. doi: 10.1016/j.jand.2013.09.023. Epub 2013 Nov 26. J Acad Nutr Diet. 2014. PMID: 24287284 Clinical Trial. - Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis.
Gerards MC, Terlou RJ, Yu H, Koks CH, Gerdes VE. Gerards MC, et al. Atherosclerosis. 2015 Jun;240(2):415-23. doi: 10.1016/j.atherosclerosis.2015.04.004. Epub 2015 Apr 12. Atherosclerosis. 2015. PMID: 25897793 Review. - Herbs and atherosclerosis.
Heber D. Heber D. Curr Atheroscler Rep. 2001 Jan;3(1):93-6. doi: 10.1007/s11883-001-0016-9. Curr Atheroscler Rep. 2001. PMID: 11123854 Review.
Cited by
- Comparative Chemical Profiling and Monacolins Quantification in Red Yeast Rice Dietary Supplements by 1H-NMR and UHPLC-DAD-MS.
Hachem R, Assemat G, Balayssac S, Martins-Froment N, Gilard V, Martino R, Malet-Martino M. Hachem R, et al. Molecules. 2020 Jan 13;25(2):317. doi: 10.3390/molecules25020317. Molecules. 2020. PMID: 31941089 Free PMC article. - Effects of xuezhikang on proliferation and adhesion capacity of cultured endothelial progenitor cells: An in vitro study.
Kong XQ, Wang MZ, Wang LX, Kong JB, Qi XW, Chen SF. Kong XQ, et al. Curr Ther Res Clin Exp. 2008 Jun;69(3):252-9. doi: 10.1016/j.curtheres.2008.06.007. Curr Ther Res Clin Exp. 2008. PMID: 24692803 Free PMC article. - Isoflavones enhance pharmacokinetic exposure of active lovastatin acid via the upregulation of carboxylesterase in high-fat diet mice after oral administration of Xuezhikang capsules.
Feng D, Ge C, Tan ZY, Sun JG, Xie Y, Yao L, Yan CX, Aa JY, Wang GJ. Feng D, et al. Acta Pharmacol Sin. 2018 Nov;39(11):1804-1815. doi: 10.1038/s41401-018-0039-1. Epub 2018 Jun 19. Acta Pharmacol Sin. 2018. PMID: 29921884 Free PMC article. - Effects of Miao sour soup on hyperlipidemia in high-fat diet-induced obese rats via the AMPK signaling pathway.
Yang H, Xie J, Wang N, Zhou Q, Lu Y, Qu Z, Wang H. Yang H, et al. Food Sci Nutr. 2021 Jun 23;9(8):4266-4277. doi: 10.1002/fsn3.2394. eCollection 2021 Aug. Food Sci Nutr. 2021. PMID: 34401077 Free PMC article. - Efficacy of Chinese herbal medicine for stroke modifiable risk factors: a systematic review.
Peng W, Lauche R, Ferguson C, Frawley J, Adams J, Sibbritt D. Peng W, et al. Chin Med. 2017 Sep 5;12:25. doi: 10.1186/s13020-017-0146-9. eCollection 2017. Chin Med. 2017. PMID: 28878815 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical